ConductScience.org, home

Paper · 31368038

Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.

Boons G and 4 others. Rev Endocr Metab Disord, 2019. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies. Papers, record 31368038. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31368038

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.
PubMed
Journal
Rev Endocr Metab Disord
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2026-10-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boons GGitta
2Vandamme TTimonhttps://orcid.org/0000-0003-3701-5305
3Peeters MMarc
4Van Camp GGuy
5Op de Beeck KKen

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Intestinal NeoplasmsMajor topic
Liquid BiopsyMajor topic
Neuroendocrine TumorsMajor topic
Animals
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References164

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,865,046A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.Gastroenterology2015https://conductscience.org/library/papers/25865046PubMed
226,058,464Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.Cancer2015https://conductscience.org/library/papers/26058464PubMed
326,446,169A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.Cancer Discov2015https://conductscience.org/library/papers/26446169PubMed
429,467,239Frequency and consequence of the recurrent YY1 p.T372R mutation in sporadic insulinomas.Endocr Relat Cancer2018https://conductscience.org/library/papers/29467239PubMed
528,903,345Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.Oncotarget2017https://conductscience.org/library/papers/28903345PubMed
624,778,027Global microRNA profiling of pancreatic neuroendocrine neoplasias.Anticancer Res2014https://conductscience.org/library/papers/24778027PubMed
725,947,577Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.Eur J Nucl Med Mol Imaging2015https://conductscience.org/library/papers/25947577PubMed
823,328,977Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.Mod Pathol2013https://conductscience.org/library/papers/23328977PubMed
930,667,365Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials.Endocr Relat Cancer2019https://conductscience.org/library/papers/30667365PubMed
1027,353,039MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.Endocr Relat Cancer2016https://conductscience.org/library/papers/27353039PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42,278,401Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors.Int J Mol Sci2026https://conductscience.org/library/papers/42278401PubMed
39,409,968The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms.Cancers (Basel)2024https://conductscience.org/library/papers/39409968PubMed
36,612,156The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses.Cancers (Basel)2022https://conductscience.org/library/papers/36612156PubMed
36,556,070Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics.J Clin Med2022https://conductscience.org/library/papers/36556070PubMed
36,085,291Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas.Oncogenesis2022https://conductscience.org/library/papers/36085291PubMed
34,759,042Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up.Clin Cancer Res2022https://conductscience.org/library/papers/34759042PubMed
34,733,354Primary tumor location (right versus left side of the colon) and resection affect the survival of patients with liver metastases from colonic neuroendocrine carcinoma: a population-based study.Ther Adv Gastroenterol2021https://conductscience.org/library/papers/34733354PubMed
33,641,005Treatment personalization in gastrointestinal neuroendocrine tumors.Curr Treat Options Oncol2021https://conductscience.org/library/papers/33641005PubMed
32,606,315Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3.Sci Rep2020https://conductscience.org/library/papers/32606315PubMed
32,537,434Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.Front Oncol2020https://conductscience.org/library/papers/32537434PubMed

1 to 10 of 11

See all 11 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATRX546PubTator's text mininghttps://conductscience.org/library/genes/546NCBI Gene
DAXX1,616PubTator's text mininghttps://conductscience.org/library/genes/1616NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31368038

GET https://conductscience.org/api/papers/v1/31368038/references?page=2